FDA Inspection 850573 — Impladent Ltd.
The FDA completed an inspection of Impladent Ltd. on September 26, 2013 in Jamaica, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 26, 2013
- Fiscal Year
- 2013
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Jamaica, NY (United States)
Additional Details
Sponsor, Contract Research Organization